|
Volumn 82, Issue 2, 2002, Pages 175-181
|
Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia
|
Author keywords
Artemether; Combined treatment; Risk for resistance development; Schistosomiasis; Toxicity studies
|
Indexed keywords
ARTEMETHER;
PRAZIQUANTEL;
DISEASE CONTROL;
DRUG DEVELOPMENT;
PARASITIC DISEASE;
SCHISTOSOMIASIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG EFFICACY;
ENDEMIC DISEASE;
HIGH RISK POPULATION;
HISTOPATHOLOGY;
HUMAN;
INCIDENCE;
INFECTION PREVENTION;
INFECTION RATE;
NEUROTOXICITY;
NONHUMAN;
PLASMODIUM BERGHEI;
SCHISTOSOMA HEMATOBIUM;
SCHISTOSOMA JAPONICUM;
SCHISTOSOMA MANSONI;
SCHISTOSOMIASIS;
TOXICITY TESTING;
WORM INFECTION;
ADMINISTRATION, ORAL;
ANIMALS;
ARTEMISININS;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
HUMANS;
PRAZIQUANTEL;
RANDOMIZED CONTROLLED TRIALS;
SCHISTOSOMA JAPONICUM;
SCHISTOSOMIASIS;
SCHISTOSOMICIDES;
SESQUITERPENES;
ANIMALIA;
HAEMATOBIA;
JAPONICA;
SCHISTOSOMA;
|
EID: 0036103409
PISSN: 0001706X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0001-706X(02)00009-8 Document Type: Conference Paper |
Times cited : (152)
|
References (22)
|